Is Augmentin (amoxicillin-clavulanate) indicated for the treatment of epistaxis in adults with suspected bacterial infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin is NOT indicated for epistaxis

Augmentin (amoxicillin-clavulanate) has no role in the routine management of epistaxis, as nosebleeds are not caused by bacterial infection and prophylactic antibiotics are not indicated even when nasal packing is used. 1, 2

Why Antibiotics Are Not Indicated

Epistaxis is a mechanical bleeding problem, not an infectious condition. The management focuses on hemostasis through:

  • First-line measures: Bidigital compression, clearing blood clots, and local vasoconstrictors (oxymetazoline) 3
  • Procedural interventions: Cauterization, nasal packing, or endoscopic techniques when first-line measures fail 4, 3
  • Advanced interventions: Arterial ligation or embolization for refractory cases 4

Evidence Against Prophylactic Antibiotics with Nasal Packing

Even when anterior nasal packing is placed—a scenario where some clinicians historically prescribed antibiotics—the evidence clearly demonstrates no benefit:

  • No documented infections occurred in patients with anterior nasal packing regardless of antibiotic use in a 5-year retrospective study of 106 patients 1
  • Bacterial growth patterns were identical between packed and non-packed sides of the nose in a prospective study, with no clinical infections observed 2
  • Current practice is inconsistent: Only 53.7% of emergency physicians prescribed prophylactic antibiotics for nasal packing, yet infection rates remained zero in both groups 1

Common Pitfall to Avoid

Do not confuse epistaxis with acute bacterial rhinosinusitis (ABRS). While Augmentin is appropriate for ABRS with risk factors for resistant organisms 5, epistaxis itself—even when associated with nasal inflammation or trauma—does not warrant antibiotic therapy 4, 3, 6.

The only scenario where antibiotics might be considered is if a patient develops secondary bacterial sinusitis as a complication, which would then be treated according to sinusitis guidelines, not epistaxis protocols 5.

References

Research

Guidelines of the French Society of Otorhinolaryngology (SFORL). First-line treatment of epistaxis in adults.

European annals of otorhinolaryngology, head and neck diseases, 2017

Research

Epistaxis Treatment Options: Literature Review.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical Study and Management of Epistaxis.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.